VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 637 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,732,300 | -65.8% | 110,000 | -68.1% | 2.37% | -64.6% |
| Q1 2024 | $10,908,900 | +151.3% | 345,000 | +146.4% | 6.70% | +214.3% |
| Q4 2023 | $4,341,400 | -24.3% | 140,000 | -30.0% | 2.13% | +0.9% |
| Q4 2022 | $5,732,000 | +2278.4% | 200,000 | +1900.0% | 2.11% | +606.4% |
| Q3 2022 | $241,000 | -92.9% | 10,000 | -90.0% | 0.30% | -71.1% |
| Q2 2021 | $3,398,000 | -64.9% | 100,000 | -69.7% | 1.04% | -38.6% |
| Q4 2019 | $9,674,000 | +22.9% | 330,400 | -22.3% | 1.68% | -30.0% |
| Q3 2018 | $7,871,000 | -63.5% | 425,000 | -56.6% | 2.41% | -60.0% |
| Q1 2018 | $21,540,000 | +826.9% | 980,000 | +880.0% | 6.02% | +570.7% |
| Q4 2017 | $2,324,000 | – | 100,000 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,165,410 | 69.82% |
| New Harbor Financial Group, LLC | 1,523,632 | $43,667,279 | 18.06% |
| Cadence Wealth Management LLC | 617,285 | $17,691,382 | 15.17% |
| Windmill Hill Asset Management Ltd | 798,150 | $22,874,979 | 14.71% |
| Slate Path Capital LP | 8,755,000 | $250,918,300 | 13.50% |
| SPX Gestao de Recursos Ltda | 3,997,000 | $114,554,020 | 12.37% |
| New Harbor Financial Group, LLC | 704,500 | $20,190,970 | 8.35% |
| Eschler Asset Management LLP | 150,000 | $4,299,000 | 8.15% |
| Hollow Brook Wealth Management LLC | 527,007 | $15,104,021 | 7.23% |
| Yong Rong (HK) Asset Management Ltd | 400,000 | $11,464 | 7.22% |